BUFFALO, N.Y. (AP) _ Athenex Inc. (ATNX) on Thursday reported a loss of $25.6 million in its first quarter.
On a per-share basis, the Buffalo, New York-based company said it had a loss of 27 cents.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.
The biopharmaceutical company posted revenue of $41 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $19.5 million.
The company's shares closed at $4.55. A year ago, they were trading at $9.45.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATNX at https://www.zacks.com/ap/ATNX
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News